Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

3.2K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
3.2K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

2.2K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

From farm to lab: gene-edited sheep transforming bone research.

JBMR plus·2026
Same author

Transcriptomic and proteomic evidence for noncanonical hydrogen sulfide metabolism and immune dysregulation in Down Syndrome.

Scientific reports·2026
Same author

Clofarabine for relapsed/refractory Langerhans cell (LC) and non-LC histiocytosis.

Blood advances·2026
Same author

Postweaning diet affects offspring metabolic outcomes more than maternal diet in male and female mice.

Physiological reports·2026
Same author

Digit regeneration in mice is stimulated by sequential treatment with FGF2 and BMP2.

Nature communications·2026
Same author

The SGLT2 Inhibitor Canagliflozin Promotes β-Cell Regeneration and Restores and Stabilises β-Cell Identity in a Polygenic Model of Severe Early-Onset Type 2 Diabetes.

Journal of cellular and molecular medicine·2026

Related Experiment Video

Updated: May 5, 2026

A Mouse Distraction Osteogenesis Model
04:24

A Mouse Distraction Osteogenesis Model

Published on: November 14, 2018

6.0K

Cisplatin inhibits bone healing during distraction osteogenesis.

Kimo C Stine1, Elizabeth C Wahl, Lichu Liu

  • 1Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, Arkansas.

Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society
|November 22, 2013
PubMed
Summary

Cisplatin chemotherapy used for osteosarcoma significantly impairs bone healing during distraction osteogenesis. This effect is dose-dependent and mediated by TNF signaling, highlighting the need for careful treatment planning.

Keywords:
chemotherapycisplatindistraction osteogenesislimb salvagemouse

More Related Videos

An Efficient and Reproducible Protocol for Distraction Osteogenesis in a Rat Model Leading to a Functional Regenerated Femur
09:26

An Efficient and Reproducible Protocol for Distraction Osteogenesis in a Rat Model Leading to a Functional Regenerated Femur

Published on: October 23, 2017

6.7K
Creating Rigidly Stabilized Fractures for Assessing Intramembranous Ossification, Distraction Osteogenesis, or Healing of Critical Sized Defects
07:35

Creating Rigidly Stabilized Fractures for Assessing Intramembranous Ossification, Distraction Osteogenesis, or Healing of Critical Sized Defects

Published on: April 11, 2012

17.7K

Related Experiment Videos

Last Updated: May 5, 2026

A Mouse Distraction Osteogenesis Model
04:24

A Mouse Distraction Osteogenesis Model

Published on: November 14, 2018

6.0K
An Efficient and Reproducible Protocol for Distraction Osteogenesis in a Rat Model Leading to a Functional Regenerated Femur
09:26

An Efficient and Reproducible Protocol for Distraction Osteogenesis in a Rat Model Leading to a Functional Regenerated Femur

Published on: October 23, 2017

6.7K
Creating Rigidly Stabilized Fractures for Assessing Intramembranous Ossification, Distraction Osteogenesis, or Healing of Critical Sized Defects
07:35

Creating Rigidly Stabilized Fractures for Assessing Intramembranous Ossification, Distraction Osteogenesis, or Healing of Critical Sized Defects

Published on: April 11, 2012

17.7K

Area of Science:

  • Orthopedics
  • Oncology
  • Regenerative Medicine

Background:

  • Osteosarcoma (OS) is a common bone cancer in children and adolescents.
  • Limb salvage surgery often involves distraction osteogenesis (DO) for bone reconstruction.
  • The impact of cisplatin (CDP), a common OS chemotherapy, on bone regeneration is not well understood.

Purpose of the Study:

  • To investigate the effects of cisplatin on direct bone formation in distraction osteogenesis.
  • To compare the impact of different cisplatin dosing regimens on bone regeneration.
  • To explore the role of TNF signaling in cisplatin's effects on bone repair.

Main Methods:

  • Utilized a distraction osteogenesis model in C57BL/6 (B6) and tumor necrosis factor receptor 1 knockout (TNFR1KO) mice.
  • Administered cisplatin chemotherapy using two different dosing regimens (five-dose and two-dose).
  • Evaluated new bone formation in the DO gaps of treated and control mice.

Main Results:

  • A five-dose regimen of cisplatin significantly reduced new bone formation in B6 mice (p < 0.001).
  • No significant inhibition of bone formation was observed in TNFR1KO mice with the five-dose regimen.
  • A two-dose regimen also significantly inhibited bone formation in B6 mice.

Conclusions:

  • Cisplatin has significant short-term negative effects on bone repair during distraction osteogenesis.
  • The inhibitory effects of cisplatin on bone regeneration are, at least partly, mediated by TNF signaling.
  • These findings support the development of strategies to mitigate chemotherapy's impact on bone healing.